Biomarkers help predict prostate cancer progression
Monday, April 19, 2010 - 13:21
in Health & Medicine
Researchers at Johns Hopkins have evaluated a simple, more specific blood test that identifies patients undergoing proactive surveillance for low-grade, low-stage, non-palpable prostate cancer who would eventually require treatment.
